In recent years researchers have gained a greater understanding of
the immunological and inflammatory mechanisms underlying rheumatoid
arthritis. Much of their efforts have centred on the role of the
cytokine network in the pathophysiology of the disease. On the
basis of these discoveries pharmaceutical companies have developed
several potential biologic agents aimed at addressing cytokine
imbalance and its subsequent effects on cartilage damage and joint
destruction in rheumatoid arthritis. This pocketbook will provide
an overview of the role of cytokines in the disease process, with a
particular focus on one cytokine, interleukin-1 (IL-1) and on the
therapeutic efficacy of its inhibition.
|Country of origin:
• Jean-Michel Dayer
||Electronic book text
Clinical & internal medicine >
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!